Article Details
Retrieved on: 2021-06-16 22:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
L) in December agreed to buy Alexion for $39 billion. Existing treatments for generalized myasthenia gravis are associated with burdensome short- ...
Article found on: www.reuters.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here